chr19-7477425-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080662.4(PEX11G):c.503G>A(p.Arg168Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000234 in 1,450,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R168W) has been classified as Uncertain significance.
Frequency
Consequence
NM_080662.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PEX11G | NM_080662.4 | c.503G>A | p.Arg168Gln | missense_variant | 5/5 | ENST00000221480.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PEX11G | ENST00000221480.6 | c.503G>A | p.Arg168Gln | missense_variant | 5/5 | 1 | NM_080662.4 | P1 | |
PEX11G | ENST00000593942.5 | c.293G>A | p.Arg98Gln | missense_variant | 7/7 | 5 | |||
PEX11G | ENST00000593547.1 | c.454-172G>A | intron_variant | 5 | |||||
PEX11G | ENST00000599519.1 | n.305G>A | non_coding_transcript_exon_variant | 4/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000644 AC: 4AN: 62104Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 32982
GnomAD4 exome AF: 0.0000193 AC: 25AN: 1298526Hom.: 0 Cov.: 31 AF XY: 0.0000189 AC XY: 12AN XY: 633900
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152308Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 30, 2023 | The c.503G>A (p.R168Q) alteration is located in exon 5 (coding exon 5) of the PEX11G gene. This alteration results from a G to A substitution at nucleotide position 503, causing the arginine (R) at amino acid position 168 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at